United Therapeutics Corporation Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax
United Therapeutics Corporation (UTHR) reported Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax · last filed 2026-08-05
- United Therapeutics Corporation other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax for the quarter ending 2026-06-30 was $0.00.
- United Therapeutics Corporation other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax for the quarter ending 2026-03-31 was $100.00K.
- United Therapeutics Corporation other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax for the quarter ending 2025-12-31 was $100.00K, a 50.00% decline year-over-year.
- United Therapeutics Corporation other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax for the quarter ending 2025-09-30 was -$1.00M.
- United Therapeutics Corporation other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax for fiscal 2025 was -$3.70M.
- United Therapeutics Corporation other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax for fiscal 2024 was -$300.00K, a 115.00% decline from fiscal 2023.
- United Therapeutics Corporation other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax for fiscal 2023 was $2.00M, a 89.30% decline from fiscal 2022.
- United Therapeutics Corporation other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax for fiscal 2022 was $18.70M, a 233.93% increase from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax 3 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax 3 month as first filed | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax 6 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax 6 month as first filed | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax 9 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax 9 month as first filed | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax 12 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | $100.00K 10-Q · filed 2026-08-05 | $200.00K derived: sum of 3 quarters · filed 2026-08-05 | -$800.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-06 | $200.00K derived: sum of 2 quarters · filed 2026-05-06 | -$800.00K derived: sum of 3 quarters · filed 2026-05-06 | -$800.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$900.00K derived: sum of 2 quarters · filed 2026-02-25 | -$900.00K derived: sum of 3 quarters · filed 2026-08-05 | -$3.70M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$1.00M 10-Q · filed 2025-10-29 | -$1.00M derived: sum of 2 quarters · filed 2026-08-05 | -$3.80M 10-Q · filed 2025-10-29 | -$3.60M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 | -$2.80M 10-Q · filed 2026-08-05 | -$2.60M derived: sum of 3 quarters · filed 2026-08-05 | -$2.60M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$2.80M 10-Q · filed 2026-05-06 | -$2.60M derived: sum of 2 quarters · filed 2026-05-06 | -$2.60M derived: sum of 3 quarters · filed 2026-05-06 | -$2.60M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $200.00K derived: sum of 2 quarters · filed 2026-02-25 | $200.00K derived: sum of 3 quarters · filed 2026-02-25 | -$300.00K 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | -$500.00K 10-Q · filed 2025-10-29 | $2.40M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $0.00 10-Q · filed 2025-07-30 | -$500.00K 10-Q · filed 2025-07-30 | $2.40M derived: sum of 3 quarters · filed 2026-02-25 | $2.40M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | -$500.00K 10-Q · filed 2025-04-30 | $2.40M derived: sum of 2 quarters · filed 2026-02-25 | $2.40M derived: sum of 3 quarters · filed 2026-02-25 | $2.40M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.90M derived: sum of 2 quarters · filed 2026-02-25 | $2.90M derived: sum of 3 quarters · filed 2026-02-25 | $2.00M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | -$900.00K 10-Q · filed 2024-10-30 | $17.60M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $0.00 10-Q · filed 2024-07-31 | -$900.00K 10-Q · filed 2024-07-31 | $17.60M derived: sum of 3 quarters · filed 2025-02-26 | $17.60M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | -$900.00K 10-Q · filed 2024-05-01 | $17.60M derived: sum of 2 quarters · filed 2025-02-26 | $17.60M derived: sum of 3 quarters · filed 2025-02-26 | $17.60M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $18.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $18.50M derived: sum of 2 quarters · filed 2025-02-26 | $18.50M derived: sum of 3 quarters · filed 2025-02-26 | $18.70M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $200.00K 10-Q · filed 2023-11-01 | $5.60M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-02 | $200.00K 10-Q · filed 2023-08-02 | $5.60M derived: sum of 3 quarters · filed 2024-02-21 | $5.60M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $200.00K 10-Q · filed 2023-05-03 | $5.60M derived: sum of 2 quarters · filed 2024-02-21 | $5.60M derived: sum of 3 quarters · filed 2024-02-21 | $5.60M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $5.40M derived: sum of 2 quarters · filed 2024-02-21 | $5.40M derived: sum of 3 quarters · filed 2024-02-21 | $5.60M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $200.00K 10-Q · filed 2022-11-02 | -$8.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-03 | $200.00K 10-Q · filed 2022-08-03 | -$8.00M derived: sum of 3 quarters · filed 2023-02-22 | -$8.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-04 | -$8.00M derived: sum of 2 quarters · filed 2023-02-22 | -$8.00M derived: sum of 3 quarters · filed 2023-02-22 | -$8.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | -$8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$8.20M derived: sum of 2 quarters · filed 2023-02-22 | -$8.20M derived: sum of 3 quarters · filed 2023-02-22 | -$8.00M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-03 | $0.00 derived: sum of 2 quarters · filed 2021-11-03 | $200.00K 10-Q · filed 2021-11-03 | -$9.80M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-04 | $200.00K 10-Q · filed 2021-08-04 | -$9.80M derived: sum of 3 quarters · filed 2022-02-24 | -$9.80M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-05 | -$9.80M derived: sum of 2 quarters · filed 2022-02-24 | -$9.80M derived: sum of 3 quarters · filed 2022-02-24 | -$10.40M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$10.00M derived: sum of 2 quarters · filed 2022-02-24 | -$10.60M derived: sum of 3 quarters · filed 2022-02-24 | -$10.60M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2020-10-28 | -$600.00K derived: sum of 2 quarters · filed 2020-10-28 | -$600.00K 10-Q · filed 2020-10-28 | |||||
| 2019-06-30 | -$600.00K 10-Q · filed 2020-07-29 | -$600.00K 10-Q · filed 2020-07-29 | ||||||
| 2018-12-31 | $10.70M 10-K · filed 2021-02-24 | |||||||
| 2017-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$1.60M derived: sum of 2 quarters · filed 2020-02-26 | -$1.60M derived: sum of 3 quarters · filed 2020-02-26 | -$1.70M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $0.00 derived: sum of 2 quarters · filed 2018-10-31 | -$100.00K 10-Q · filed 2018-10-31 | $0.00 derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$100.00K 10-Q · filed 2018-08-01 | $0.00 derived: sum of 3 quarters · filed 2019-02-27 | -$1.20M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | -$100.00K 10-Q · filed 2018-05-02 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | -$1.20M derived: sum of 3 quarters · filed 2019-02-27 | $5.90M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$1.10M derived: sum of 2 quarters · filed 2019-02-27 | $6.00M derived: sum of 3 quarters · filed 2019-02-27 | $6.00M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | -$1.20M 10-Q · filed 2017-10-25 | $5.90M derived: sum of 2 quarters · filed 2017-10-25 | $5.90M 10-Q · filed 2017-10-25 | |||||
| 2016-06-30 | $7.10M 10-Q · filed 2017-07-27 | $7.10M 10-Q · filed 2017-07-27 | ||||||
| 2015-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $2.80M derived: sum of 2 quarters · filed 2018-02-21 | $2.80M derived: sum of 3 quarters · filed 2018-02-21 | $700.00K 10-K · filed 2018-02-21 | $826.00K 10-K · filed 2016-02-25 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $0.00 derived: sum of 2 quarters · filed 2016-10-27 | -$2.10M 10-Q · filed 2016-10-27 | -$2.11M 10-Q · filed 2015-10-27 | $679.00K derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$2.10M 10-Q · filed 2016-07-28 | -$2.11M 10-Q · filed 2015-07-28 | $679.00K derived: sum of 3 quarters · filed 2017-02-22 | $679.00K derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-03-31 | -$2.10M 10-Q · filed 2016-04-28 | -$2.11M 10-Q · filed 2015-04-28 | $679.00K derived: sum of 2 quarters · filed 2017-02-22 | $679.00K derived: sum of 3 quarters · filed 2017-02-22 | $679.00K derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $2.78M derived: sum of 2 quarters · filed 2017-02-22 | $2.78M derived: sum of 3 quarters · filed 2017-02-22 | $3.00M 10-K · filed 2017-02-22 | $3.00M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $0.00 derived: sum of 2 quarters · filed 2015-10-27 | $221.00K 10-Q · filed 2015-10-27 | $2.25M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | $221.00K 10-Q · filed 2015-07-28 | $2.25M derived: sum of 3 quarters · filed 2016-02-25 | $2.25M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $221.00K 10-Q · filed 2015-04-28 | $2.25M derived: sum of 2 quarters · filed 2016-02-25 | $2.25M derived: sum of 3 quarters · filed 2016-02-25 | $2.25M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $2.02M derived: sum of 2 quarters · filed 2016-02-25 | $2.02M derived: sum of 3 quarters · filed 2016-02-25 | $2.08M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $0.00 derived: sum of 2 quarters · filed 2014-10-28 | $51.00K 10-Q · filed 2014-10-28 | -$5.37M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | $51.00K 10-Q · filed 2014-07-29 | -$5.37M derived: sum of 3 quarters · filed 2015-02-24 | -$5.37M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $51.00K 10-Q · filed 2014-04-29 | -$5.37M derived: sum of 2 quarters · filed 2015-02-24 | -$5.37M derived: sum of 3 quarters · filed 2015-02-24 | -$5.37M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | -$5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$5.42M derived: sum of 2 quarters · filed 2015-02-24 | -$5.42M derived: sum of 3 quarters · filed 2015-02-24 | -$5.35M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $0.00 derived: sum of 2 quarters · filed 2013-10-29 | $64.00K 10-Q · filed 2013-10-29 | $309.00K derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $64.00K 10-Q · filed 2013-07-25 | $309.00K derived: sum of 3 quarters · filed 2014-02-25 | $322.00K derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $64.00K 10-Q · filed 2013-04-25 | $309.00K derived: sum of 2 quarters · filed 2014-02-25 | $322.00K derived: sum of 3 quarters · filed 2014-02-25 | $336.00K derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $258.00K derived: sum of 2 quarters · filed 2014-02-25 | $272.00K derived: sum of 3 quarters · filed 2014-02-25 | $431.00K 10-K · filed 2014-02-25 | $487.00K 10-K · filed 2012-02-28 | |||
| 2011-09-30 | $13.00K 10-Q · filed 2011-10-27 | $27.00K derived: sum of 2 quarters · filed 2011-10-27 | $186.00K 10-Q · filed 2012-11-01 | $231.00K 10-Q · filed 2011-10-27 | -$370.00K derived: sum of 4 quarters · filed 2013-02-26 | |||
| 2011-06-30 | $14.00K 10-Q · filed 2011-07-28 | $186.00K 10-Q · filed 2012-07-26 | $218.00K 10-Q · filed 2011-07-28 | -$383.00K derived: sum of 3 quarters · filed 2013-02-26 | -$861.00K derived: sum of 4 quarters · filed 2013-02-26 | |||
| 2011-03-31 | $186.00K 10-Q · filed 2012-04-26 | -$397.00K derived: sum of 2 quarters · filed 2013-02-26 | -$875.00K derived: sum of 3 quarters · filed 2013-02-26 | -$858.00K derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | -$583.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$1.06M derived: sum of 2 quarters · filed 2013-02-26 | -$1.04M derived: sum of 3 quarters · filed 2013-02-26 | -$1.20M 10-K · filed 2013-02-26 | -$4.35M 10-K · filed 2011-02-24 | |||
| 2010-09-30 | -$478.00K 10-Q · filed 2011-10-27 | -$461.00K derived: sum of 2 quarters · filed 2011-10-27 | -$620.00K 10-Q · filed 2011-10-27 | |||||
| 2010-06-30 | $17.00K 10-Q · filed 2011-07-28 | -$144.00K 10-Q · filed 2011-07-28 | ||||||
| 2009-12-31 | -$1.34M 10-K · filed 2012-02-28 | -$1.25M 10-K · filed 2011-02-24 | ||||||
| 2008-12-31 | -$550.00K 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |